Related Experiment Video
Updated: Oct 2, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
Ibrahim El-Battrawy1,2, Boldizsar Kovacs3, Tobias C Dreher4
1Bergmannsheil University Medical Center, Ruhr University Bochum, Bochum, Germany. Ibrahim.elbattrawy2006@gmail.com.
Insights
Wearable cardioverter defibrillators (WCD) offer an alternative to immediate implantable cardioverter defibrillators (ICD) for high-risk patients. Real-world data show high compliance, with younger patients exhibiting lower wear time.
Area of Science:
- Cardiology
- Medical Devices
- Public Health
Background:
- Sudden cardiac death (SCD) risk necessitates preventative strategies.
- Wearable cardioverter defibrillators (WCD) provide a temporary solution, potentially delaying or avoiding implantable cardioverter defibrillators (ICD).
- Patient selection, compliance, and optimal medical therapy are crucial for WCD effectiveness.
Purpose of the Study:
- To evaluate real-world data on WCD use in high-risk SCD patients.
- To analyze factors influencing WCD compliance and outcomes.
- To compare outcomes between German and Swiss patient cohorts.
Main Methods:
- A registry study involving 708 patients across 4 centers in Germany and Switzerland (04/2012-03/2019).
- Analysis of patient demographics, etiologies of cardiomyopathy, WCD wear time, left ventricular ejection fraction (LVEF), and shock rates.
- Comparison of outcomes between German and Swiss patients.
Main Results:
- The study included 708 patients (81.8% male, mean age 61.0 years). Common etiologies were non-ischemic (44.6%) and ischemic cardiomyopathy (39.8%).
- Mean WCD wear time was 21.2 hours/day, with high overall compliance. Younger patients showed lower wear hours.
- The total shock rate was 2.7% (2.2% appropriate WCD shocks, 0.5% inappropriate ICD shocks). ICD implantation occurred in 34.5% of patients. Swiss patients had longer wear days and higher ICD implantation rates than German patients.
Conclusions:
- WCDs are a viable option for high-risk SCD patients, demonstrating high compliance in real-world settings.
- Younger age was identified as a negative predictor for WCD compliance.
- Differences in wear time and ICD implantation rates between German and Swiss patients suggest potential variations in clinical practice or patient mentality.
Abstract:
Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatment. We aimed to present real world data from 4 centers from Germany and Switzerland. Between 04/2012 and 03/2019, 708 patients were included in this registry. Patients were followed up over a mean time of 28 ± 35.5 months. Outcome data including gender differences and different etiologies of cardiomyopathy were analyzed. Out of 708 patients (81.8% males, mean age 61.0 ± 14.6), 44.6% of patients had non-ischemic cardiomyopathy, 39.8% ischemic cardiomyopathy, 7.9% myocarditis, 5.4% prior need for ICD explantation and 2.1% channelopathy. The mean wear time of WCD was 21.2 ± 4.3 h per day. In 46% of patients, left ventricular ejection fraction (LVEF) was > 35% during follow-up. The younger the patient was, the higher the LVEF and the lower the wear hours per day were. The total shock rate during follow-up was 2.7%. Whereas an appropriate WCD shock was documented in 16 patients (2.2%), 3 patients received an inappropriate ICD shock (0.5%). During follow-up, implantation of a cardiac implantable electronic device was carried out in 34.5% of patients. When comparing German patients (n = 516) to Swiss patients (n = 192), Swiss patients presented with longer wear days (70.72 ± 49.47 days versus 58.06 ± 40.45 days; p = 0.001) and a higher ICD implantation rate compared to German patients (48.4% versus 29.3%; p = 0.001), although LVEF at follow-up was similar between both groups. Young age is a negative independent predictor for the compliance in this large registry. The most common indication for WCD was non-ischemic cardiomyopathy followed by ischemic cardiomyopathy. The compliance rate was generally high with a decrease of wear hours per day at younger age. Slight differences were found between Swiss and German patients, which might be related to differences in mentality for ICD implantation.
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy V: Interprofessional Care
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Cardiopulmonary Resuscitation I: Adult
Cardiac Catheterization II: Right Heart Catheterization
Cardiomyopathy II: Dilated Cardiomyopathy

